A new treatment for hypoxic brain injury?
Flood
Pamela
P
D000109:Acetylcholine / Q000378:metabolism; D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects* / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects*; D003072:Cognition Disorders / Q000201:enzymology / Q000209:etiology / Q000517:prevention & control*; D004195:Disease Models, Animal; D005106:Exploratory Behavior / Q000187:drug effects; D006801:Humans; D002534:Hypoxia, Brain / Q000188:drug therapy* / Q000201:enzymology / Q000523:psychology; D008568:Memory / Q000187:drug effects; D018697:Nootropic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D010830:Physostigmine / Q000494:pharmacology* / Q000627:therapeutic use; D012107:Research Design; D012720:Severity of Illness Index; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents; D010830:Physostigmine; D000110:Acetylcholinesterase; D000109:Acetylcholine